Article info

Successful integration of newborn genetic testing into UK routine screening using prospective consent to determine eligibility for clinical trials

Authors

  1. Correspondence to Manu Vatish, Nuffield Department of Women’s & Reproductive Health, University of Oxford, Oxford, UK; manu.vatish{at}wrh.ox.ac.uk
View Full Text

Citation

Bendor-Samuel OM, Wishlade T, Willis L the GPPAD Study Group, et al
Successful integration of newborn genetic testing into UK routine screening using prospective consent to determine eligibility for clinical trials

Publication history

  • Received April 8, 2022
  • Accepted September 9, 2022
  • First published September 28, 2022.
Online issue publication 
May 17, 2023

Article Versions

  • Supplementary Data

    This web only file has been produced by the BMJ Publishing Group from an electronic file supplied by the author(s) and has not been edited for content.

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.